| MR编号 | NL/H/3368/003 |
|---|
| 药品名称 | Rapibloc 20 mg/2 ml concentrate for solution for injection |
|---|
| 活性成分 | - Landiolol hydrochloride 20.0 mg/2 ml
|
|---|
| 剂型 | Concentrate for solution for injection |
|---|
| 上市许可持有人 | AOP Orphan Pharmaceuticals AG
Wilhelminenstrasse 91/II f
1160 Vienna
Austria |
|---|
| 参考成员国 - 产品名称 | Netherlands (NL) Rapibloc 20 mg/2 ml Concentraat voor oplossing voor injectie |
|---|
| 互认成员国 - 产品名称 | - Germany (DE)
Rapibloc 20 mg/2 ml Konzentrat zur Herstellung einer Injektionslösung - Denmark (DK)
- Austria (AT)
Rapibloc 20 mg/2 ml Konzentrat zur Herstellung einer Injektionslösung - France (FR)
RAPIBLOC - Italy (IT)
- Greece (GR)
RAPIBLOC - Sweden (SE)
- Norway (NO)
- Finland (FI)
- Poland (PL)
Runrapiq - Latvia (LV)
Raploc 20 mg/2 ml koncentrāts injekciju šķīduma pagatavošanai - Lithuania (LT)
Raploc 20 mg / 2 ml koncentratas injekciniam tirpalui - Estonia (EE)
RAPLOC - Hungary (HU)
RAPIBLOC 20 mg/2 ml koncentrátum oldatos injekcióhoz - Bulgaria (BG)
Rapibloc - Cyprus (CY)
- Czechia (CZ)
Rapibloc 20 mg/2 ml Koncentrát pro injekční roztok - Romania (RO)
RAPIBLOC 20 mg/2 ml concentrat pentru soluție injectabilă - Slovakia (SK)
Rapibloc 20 mg/2 ml injekčný koncentrát - Slovenia (SI)
- Croatia (HR)
|
|---|
| 许可日期 | 2016/06/29 |
|---|
| 最近更新日期 | 2024/10/20 |
|---|
| 药物ATC编码 | - C07A BETA BLOCKING AGENTS
| 申请类型 | - TypeLevel1：New Active Substance
- TypeLevel2：Initial Application
- TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|